Survival outcome is similar for first-line chemotherapy with capecitabine or taxane for metastatic breast cancer

被引：0
|
作者：
Kimmick, G. G.
Camacho, F.
Wei, W.
Balkrishnan, R.
Anderson, R.
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Penn State Coll Med, Hershey, PA USA
[3] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA
[4] Ohio State Univ, Sch Publ Hlth, Columbus, OH 43210 USA
[5] Roche, Nutley, NJ USA
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：374S / 374S
页数：1
相关论文
共 50 条
  • [1] Similar survival with single-agent capecitabine or taxane in first-line therapy for metastatic breast cancer
    Kamal, A. H.
    Camacho, F.
    Anderson, R.
    Wei, W.
    Balkrishnan, R.
    Kimmick, G.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (01) : 371 - 378
  • [2] Similar survival with single-agent capecitabine or taxane in first-line therapy for metastatic breast cancer
    A. H. Kamal
    F. Camacho
    R. Anderson
    W. Wei
    R. Balkrishnan
    G. Kimmick
    Breast Cancer Research and Treatment, 2012, 134 : 371 - 378
  • [3] Addition of Capecitabine in Breast Cancer First-line Chemotherapy Improves Survival of Breast Cancer Patients
    Xu, Di
    Chen, Xiu
    Li, Xingjiang
    Mao, Zhixiang
    Tang, Wenjuan
    Zhang, Wei
    Ding, Li
    Tang, Jinhai
    JOURNAL OF CANCER, 2019, 10 (02): : 418 - 429
  • [4] First-Line Chemotherapy for Metastatic Breast Cancer
    Telli, Melinda L.
    Carlson, Robert W.
    CLINICAL BREAST CANCER, 2009, 9 : S66 - S72
  • [5] First-line Bevacizumab Plus Taxane-based Chemotherapy for Metastatic Breast Cancer (mBC)
    Bazan, F.
    Dobi, E.
    Villanueva, C.
    Nerich, V.
    Compagnat, F.
    Thiery-Vuillemin, A.
    Chaigneau, L.
    Nguyen, T.
    Limat, S.
    Pivot, X.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S345 - S345
  • [6] Impact of cachexia on survival before first-line chemotherapy for metastatic breast cancer
    Nozawa, Kazuki
    Isogai, Ayaka
    Takatsuka, Daiki
    Endo, Yuka
    Ozaki, Yuri
    Horisawa, Nanae
    Kataoka, Ayumi
    Kotani, Haruru
    Yoshimura, Akiyo
    Hattori, Masaya
    Sawaki, Masataka
    Iwata, Hiroji
    ANNALS OF ONCOLOGY, 2022, 33 : S491 - S492
  • [7] Phase II trial of capecitabine and vinorelbine as first-line chemotherapy for metastatic breast cancer patients
    Ghosn, M
    Kattan, J
    Farhat, F
    Younes, F
    Gasmi, J
    ANTICANCER RESEARCH, 2006, 26 (3B) : 2451 - 2456
  • [8] DURATION OF FIRST-LINE CHEMOTHERAPY IN METASTATIC BREAST CANCER
    Gennari, Alessandra
    Provinciali, Nicoletta
    BREAST, 2015, 24 : S31 - S31
  • [9] Administration of further chemotherapy (CT) after capecitabine as first-line chemotherapy (CT) for metastatic breast cancer (MBC)
    Debled, M.
    Trainaud, A.
    Durand, M.
    Floquet, A.
    Brouste, V.
    Mauriac, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] The role of capecitabine in first-line treatment for patients with metastatic breast cancer
    Gelmon, Karen
    Chan, Arlene
    Harbeck, Nadia
    ONCOLOGIST, 2006, 11 : 42 - 51
12345